Expression of concern highlights a potential conflict of interest involving Dr. Unfer, pointing to possible bias in research findings on PCOS.
The Editor in Chief and the Publisher are issuing an expression of concern regarding the following article: Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte and embryo quality in PCOS patients having a normal insulin response. Eur Rev Med Pharmacol Sci. 2011 Apr; 15(4): 452-457. PMID: 21608442. This Expression of Concern is issued following a notification from a third party concerning a potential conflict of interest involving Dr. Unfer's role at Loli Pharma, the company marketing inositol-based products. This expression of concern aims to notify a possible bias arising from an undeclared conflict of interest. The authors have been notified of both the ongoing investigation and the publication of this notice. https://www.europeanreview.org/article/929.
No takes yet. Share an insight, caveat, or question.
No Authors Listed (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: